Semaglutide, the scientific name for Novos GLP-1 diabetes drug Ozempic and obesity drug Wegovy, has been on the shortage list for over two years, with different doses being listed in shortage at various times
Ozempic is FDA approved for type 2 diabetes, while Wegovy is approved for chronic weight management
What purity standards does NewBioRx maintain for research peptides
TRC Healthcare Editor Hosts: Stephen Small, PharmD, BCPS, BCPPS, BCCCP, CNSC Don Weinberger, PharmD, PMSP Guest: Sara Klockars, PharmD, BCPS (TRC Healthcare Editor, Dermatology Specialist) CE Information: None of the speakers have anything to disclose